Agency Forms Undergoing Paperwork Reduction Act Review, 74097-74098 [2014-29289]
Download as PDF
74097
Federal Register / Vol. 79, No. 240 / Monday, December 15, 2014 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
State Administrators ........................................
District Administrators .....................................
School Administrators .....................................
State-level Recruitment Script for the NYTS
District-level Recruitment Script for the NYTS
School-level Recruitment Script for the
NYTTS.
Data Collection Checklist for the NYTS .........
National Youth Tobacco Survey ....................
Teachers .........................................................
Students ..........................................................
LeRoy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–29218 Filed 12–12–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30-Day 15–14AUI]
emcdonald on DSK67QTVN1PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
VerDate Sep<11>2014
02:54 Dec 13, 2014
Jkt 235001
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
WISEWOMAN National Program
Evaluation—New—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The CDC has supported the
WISEWOMAN program (Well-Integrated
Screening and Evaluation for Women
Across the Nation) since 1995. The
WISEWOMAN program is designed to
serve low-income women ages 40–64
who have elevated risk factors for
cardiovascular disease (CVD) and have
no health insurance, or are
underinsured for medical and
preventive care services. Through the
WISEWOMAN program, women have
access to screening services for selected
CVD risk factors such as elevated blood
cholesterol, hypertension, and abnormal
blood glucose levels; referrals to
lifestyle programs; and referrals to
medical care. WISEWOMAN
participants must be co-enrolled in the
CDC-sponsored National Breast and
Cervical Cancer Early Detection Program
(NBCCEDP).
The WISEWOMAN program is
administered through cooperative
agreements with state, territorial, or
tribal health departments. At present,
approximately two-thirds of program
funding is provided by CDC with the
other one-third supplied by the state,
territory, or tribal organization. Each
WISEWOMAN awardee submits to CDC
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
Average burden per response
(in hours)
Number of respondents
Type of respondent
Number of responses per
respondent
35
150
220
1
1
1
30/60
30/60
30/60
973
20,077
1
1
15/60
45/60
an annual progress report that describes
program objectives and activities, and
semi-annual data reports (known as
minimum data elements, or MDE) on
the screening, assessment, and lifestyle
program services offered to women who
participate in the program (see
WISEWOMAN Reporting System, OMB
No. 0920–0612, exp. 12/31/2016).
Participant-level MDE are de-identified
prior to transmission to CDC.
In 2013, CDC released the fourth
funding opportunity announcement
(FOA) for the WISEWOMAN program
(DP13–1302), which resulted in fouryear cooperative agreements with 22
state, territorial, and tribal health
departments, including 5 new and 17
continuing awardees from the previous
FOA. Key program elements were
retained (e.g., provision of screening
services, promotion of healthy lifestyle
behaviors, and linkage to community
resources), but a number of changes
were incorporated into the program at
that time due to shifts in populations,
systems, and community needs. The
current FOA reflects increased emphasis
on improving access to clinical systems
of care and increased emphasis on
leveraging existing resources in the
community. Lifestyle interventions have
also been reframed to include lifestyle
programs and health coaching sessions,
and MDE have been updated to capture
information about risk reduction
counseling and participants’ readiness
to change. The current cooperative
agreement also stresses monitoring and
performance evaluation as key program
dimensions. Additionally, more
information is needed to augment that
from previous evaluation efforts.
CDC seeks to conduct a one-time,
multi-component evaluation to assess
the effectiveness of the program on
individual-, organizational-, and
community-level outcomes. The indepth assessment is designed to
complement the routine progress and
MDE information already being
collected from WISEWOMAN program
awardees. The new data collection will
focus on obtaining qualitative and
E:\FR\FM\15DEN1.SGM
15DEN1
74098
Federal Register / Vol. 79, No. 240 / Monday, December 15, 2014 / Notices
quantitative information at the
organizational and community levels
about process and procedures
implemented, and barriers, facilitators,
and other contextual factors that affect
program implementation and
participant outcomes. Data collection
activities will include a Program Survey
with all WISEWOMAN awardee
programs, administered in the second
and fourth program years; a Network
Survey of WISEWOMAN awardees and
partner organizations, also conducted in
the second and fourth program years;
and a one-time Site Visit to a subset of
awardees across the second to fourth
program years. During site visits, semistructured discussions will be
conducted with WISEWOMAN staff and
partner members who serve in diverse
roles and are positioned to provide a
variety of perspectives on program
implementation.
OMB approval is requested for three
years. Participation is voluntary and
there are no costs to respondents other
than their time. The total estimated
annualized burden hours are 132.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
WISEWOMAN Awardee Administrators .........
Program Survey .............................................
Network Survey ..............................................
Site Visit Discussion Guide ............................
Network Survey ..............................................
Site Visit Discussion Guide ............................
Site Visit Discussion Guide ............................
Site Visit Discussion Guide ............................
Awardee Partners ...........................................
Healthy Behavior Support staff .......................
Clinical Providers ............................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–29289 Filed 12–12–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day-15–15GJ]
emcdonald on DSK67QTVN1PROD with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
The Centers for Disease Control and
Prevention (CDC), as part of its
continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. To request more
information on the below proposed
project or to obtain a copy of the
information collection plan and
instruments, call 404–639–7570 or send
comments to Leroy A. Richardson, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments submitted in response to
this notice will be summarized and/or
included in the request for Office of
Management and Budget (OMB)
approval. Comments are invited on: (a)
VerDate Sep<11>2014
04:14 Dec 13, 2014
Jkt 235001
Whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected;(d) ways to
minimize the burden of the collection of
information on respondents, including
through the use of automated collection
techniques or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. Written comments should
be received within 60 days of this
notice.
Proposed Project
Title of Project—Investigating the
Implementation and Evaluation of Topranked HSMS Elements — New—
National Institute for Occupational
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
15
15
6
147
12
12
12
Number of
responses per
respondent
Avg. burden
per response
(in hr)
1
1
1
1
1
1
1
1
30/60
75/60
30/60
45/60
45/60
45/60
Safety and Health (NIOSH), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
NIOSH, under Pub. L. 91–596,
Sections 20 and 22 (Section 20–22,
Occupational Safety and Health Act of
1977) has the responsibility to conduct
research relating to innovative methods,
techniques, and approaches dealing
with occupational safety and health
problems.
This project seeks to understand the
best practices for developing,
implementing, and maintaining a robust
risk management system (i.e. health and
safety management system [HSMS]).
Researchers suggest that an HSMS
requires considerable knowledge, skills,
abilities, and competencies from all
individuals within an organization as
well as focused and purposeful
coordination between them.
Previous research considered the
sheer number of possible choices to be
a barrier to HSMS adoption. Therefore,
NIOSH began to understand what the
most fundamentally important elements
were that support the development,
implementation and maintenance of a
comprehensive, effective risk-based
HSMS. NIOSH surveyed practicing
health and safety executives, managers,
and professionals from a variety of
mining commodities to determine if
they agreed on which HSMS elements
and practices were most important. The
results of this study suggested that the
following areas require consistent focus
and attention: Leadership Development;
Accountability; Knowledge, Skills, and
Abilities Development; System
Coordination; Culture Enhancement;
E:\FR\FM\15DEN1.SGM
15DEN1
Agencies
[Federal Register Volume 79, Number 240 (Monday, December 15, 2014)]
[Notices]
[Pages 74097-74098]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-29289]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30-Day 15-14AUI]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
WISEWOMAN National Program Evaluation--New--National Center for
Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The CDC has supported the WISEWOMAN program (Well-Integrated
Screening and Evaluation for Women Across the Nation) since 1995. The
WISEWOMAN program is designed to serve low-income women ages 40-64 who
have elevated risk factors for cardiovascular disease (CVD) and have no
health insurance, or are underinsured for medical and preventive care
services. Through the WISEWOMAN program, women have access to screening
services for selected CVD risk factors such as elevated blood
cholesterol, hypertension, and abnormal blood glucose levels; referrals
to lifestyle programs; and referrals to medical care. WISEWOMAN
participants must be co-enrolled in the CDC-sponsored National Breast
and Cervical Cancer Early Detection Program (NBCCEDP).
The WISEWOMAN program is administered through cooperative
agreements with state, territorial, or tribal health departments. At
present, approximately two-thirds of program funding is provided by CDC
with the other one-third supplied by the state, territory, or tribal
organization. Each WISEWOMAN awardee submits to CDC an annual progress
report that describes program objectives and activities, and semi-
annual data reports (known as minimum data elements, or MDE) on the
screening, assessment, and lifestyle program services offered to women
who participate in the program (see WISEWOMAN Reporting System, OMB No.
0920-0612, exp. 12/31/2016). Participant-level MDE are de-identified
prior to transmission to CDC.
In 2013, CDC released the fourth funding opportunity announcement
(FOA) for the WISEWOMAN program (DP13-1302), which resulted in four-
year cooperative agreements with 22 state, territorial, and tribal
health departments, including 5 new and 17 continuing awardees from the
previous FOA. Key program elements were retained (e.g., provision of
screening services, promotion of healthy lifestyle behaviors, and
linkage to community resources), but a number of changes were
incorporated into the program at that time due to shifts in
populations, systems, and community needs. The current FOA reflects
increased emphasis on improving access to clinical systems of care and
increased emphasis on leveraging existing resources in the community.
Lifestyle interventions have also been reframed to include lifestyle
programs and health coaching sessions, and MDE have been updated to
capture information about risk reduction counseling and participants'
readiness to change. The current cooperative agreement also stresses
monitoring and performance evaluation as key program dimensions.
Additionally, more information is needed to augment that from previous
evaluation efforts.
CDC seeks to conduct a one-time, multi-component evaluation to
assess the effectiveness of the program on individual-, organizational-
, and community-level outcomes. The in-depth assessment is designed to
complement the routine progress and MDE information already being
collected from WISEWOMAN program awardees. The new data collection will
focus on obtaining qualitative and
[[Page 74098]]
quantitative information at the organizational and community levels
about process and procedures implemented, and barriers, facilitators,
and other contextual factors that affect program implementation and
participant outcomes. Data collection activities will include a Program
Survey with all WISEWOMAN awardee programs, administered in the second
and fourth program years; a Network Survey of WISEWOMAN awardees and
partner organizations, also conducted in the second and fourth program
years; and a one-time Site Visit to a subset of awardees across the
second to fourth program years. During site visits, semi-structured
discussions will be conducted with WISEWOMAN staff and partner members
who serve in diverse roles and are positioned to provide a variety of
perspectives on program implementation.
OMB approval is requested for three years. Participation is
voluntary and there are no costs to respondents other than their time.
The total estimated annualized burden hours are 132.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Avg. burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hr)
----------------------------------------------------------------------------------------------------------------
WISEWOMAN Awardee Administrators...... Program Survey.......... 15 1 1
Network Survey.......... 15 1 30/60
Site Visit Discussion 6 1 75/60
Guide.
Awardee Partners...................... Network Survey.......... 147 1 30/60
Site Visit Discussion 12 1 45/60
Guide.
Healthy Behavior Support staff........ Site Visit Discussion 12 1 45/60
Guide.
Clinical Providers.................... Site Visit Discussion 12 1 45/60
Guide.
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-29289 Filed 12-12-14; 8:45 am]
BILLING CODE 4163-18-P